Maintaining wellbeing for South Africans receiving ART: The burden of pain and symptoms is greater with longer ART exposure

South African Medical Journal

Volumn 104, Issue 2, 2014, Pages 119-123

  Farrant, L ^a   Gwyther, L ^a   Dinat, N ^b   Mmoledi, K ^b   Hatta, N ^b   Harding, R ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APPETITE DISORDER; ARTICLE; BLOATING; CD4+ T LYMPHOCYTE; CONSTIPATION; COUGHING; CROSS-SECTIONAL STUDY; DIARRHEA; DIZZINESS; DROWSINESS; DYSPHAGIA; DYSPNEA; FEMALE; HAIR LOSS; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH PAIN; NAUSEA; NERVOUSNESS; PARESTHESIA; PATIENT COMPLIANCE; PATIENT WORRY; PRURITUS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELF REPORT; SEXUAL DYSFUNCTION; SKIN TINGLING; SOUTH AFRICA; SWEAT; SYMPTOMATOLOGY; VOMITING; WEIGHT REDUCTION; WELLBEING; XEROSTOMIA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SOUTH AFRICA;

EID: 84893078901     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7461     Document Type: Article

References (30)

1. Harding R, Lampe FC, Norwood S, et al. Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect 2010;86(7):520-524. [http://dx.doi.org/10.1136/sti.2009.038505]
2. Harding R, Molloy T, Easterbrook P, Frame K, Higginson IJ. Is antiretroviral therapy associated with symptom prevalence and burden? Int J STD AIDS 2006;17(6):400-405. [http://dx.doi. org/10.1258/095646206777323409]
3. Harding R, Clucas C, Lampe FC, et al. Behavioral surveillance study: Sexual risk taking behaviour in UK HIV outpatient attendees. AIDS Behav 2012;16(6):1708-1715. [http://dx.doi.org/10.1007/s10461- 011-0023-y]
4. Sherr L, Lampe F, Norwood S, et al. Adherence to antiretroviral treatment in patients with HIV in the UK: A study of complexity. AIDS Care 2008;20(4):442-448. [http://dx.doi.org/10.1080/09540120701867032]
5. Sherr L, Lampe F, Norwood S, et al. Successive switching of antiretroviral therapy is associated with high psychological and physical burden. Int J STD AIDS 2007;18(10):700-704. [http://dx.doi. org/10.1258/095646207782193821]
6. Lampe FC, Harding R, Smith CJ, Phillips AN, Johnson M, Sherr L. Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr 2010;54(5):500-505. [http://dx.doi.org/10.1097/QAI.0b013e3181ce6afe]
7. Karus D, Raveis VH, Alexander C, et al. Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS. J Pain Symptom Manage 2005;30(5):408-417. [http://dx.doi.org/10.1016/j.jpainsymman.2005.04.011]
8. Harding R, Molloy T. Positive futures? The impact of HIV infection on achieving health, wealth and future planning. AIDS Care 2008;20(5):565-570. [http://dx.doi.org/10.1080/09540120701867222]
9. Justice AC, Chang CH, Rabeneck L, Zackin R. Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care 2001;39(4):397-408. [http://dx.doi.org/10.1097/00005650- 200104000-00010]
10. Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: Multicentre study. BMJ 1997;314(7073):23-28. [http://dx.doi.org/10.1136/bmj.314.7073.23]
11. World Health Organization. HIV/AIDS Topics: Palliative Care 2006. Geneva: WHO, 2006. http://www. who.int/hiv/topics/palliative/PalliativeCare/en/ (accessed 19 December 2013).
12. Heath KV, Montaner JS, Bondy G, Singer J, O'Shaughnessy MV, Hogg RS. Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. Curr Drug Targets 2003;4(1):13-22.
13. Dieleman JP, Jambroes M, Gyssens IC, et al. Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort. AIDS 2002;16(5):737-745. [http://dx.doi. org/10.1097/00002030-200203290-00009]
14. Selwyn P. Why should we care about palliative care for AIDS in the era of antiretroviral therapy? Sex Transm Infect 2005;81:2-3. [http://dx.doi.org/10.1136/sti.2004.011585]
15. The untapped potential of palliative care for AIDS. Lancet 2003;362(9398):1773.
16. Farrant L, Gwyther L, Dinat N, Mmoledi K, Hatta N, Harding R. The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics. S Afr Med J 2012;102(6):499-500.
17. National Department of Health, South African National AIDS Council. The South African Antiretroviral Treatment Guidelines 2010. Pretoria: NDoH, 2010. http://www.uj.ac.za/EN/CorporateServices/ioha/Documentation/Documents/ART%20Guideline.pdf (accessed 11 December 2013).
18. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer 2000;89(5):1162-1171. [http://dx.doi.org/10.1002/1097-0142(20000901)89:51162::AID-CNCR263.0.CO;2-Y]
19. Wakeham K, Harding R, Bamukama-Namakoola D, et al. Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda. J Palliat Med 2010;13(4):375-380. [http://dx.doi.org/10.1089/ jpm.2009.0259]
20. Harding R, Selman L, Agupio G, et al. Prevalence, burden, and correlates of physical and psychological symptoms among HIV palliative care patients in sub-Saharan Africa: An international multicenter study. J Pain Symptom Manage 2012 Jul;44(1):1-9. [http://dx.doi.org/10.1016/j.jpainsymman.2011.08.008]
21. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984;2(3):187-193.
22. Morgan EE, Iudicello JE, Weber E, et al. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 2012 61(3):341-348. [http://dx.doi.org/10.1097/QAI.0b013e31826bfc53]
23. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
24. Harding R, Karus D, Easterbrook P, Raveis VH, Higginson IJ, Marconi K. Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence. Sex Transm Infect 2005;81(1):5-14. [http://dx.doi.org/10.1136/sti.2004.010132]
25. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported outcome measures in healthcare settings. BMJ 2010;340:c186. [http://dx.doi.org/10.1136/bmj.c186]
26. Joint United Nations Programme on HIV/AIDS. AIDS: Palliative Care: UNAIDS Technical Update. Geneva: UNAIDS, 2000. http://apps.who.int/medicinedocs/en/d/Jh2930e/ (accessed 11 December 2013).
27. Harding R, Clucas C, Lampe FC, et al. What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors. AIDS Care 2012;24(8):963-971. [http://dx.doi.org/10.1080/09540121.2012.668175]
28. Mphahlele NR, Mitchell D, Kamerman PR. Pain in ambulatory HIV-positive South Africans. Eur J Pain 2012;16(3):447-458. [http://dx.doi.org/10.1002/j.1532-2149.2011.00031.x]
29. Peltzer K, Phaswana-Mafuya N. The symptom experience of people living with HIV and AIDS in the Eastern Cape, South Africa. BMC Health Serv Res 2008;8:271. [http://dx.doi.org/10.1186/1472-6963-8-271]
30. Namisango E, Harding R, Atuhaire L, et al. Pain among ambulatory HIV/AIDS patients: Multicenter study of prevalence, intensity, associated factors, and effect. J Pain 2012;13(7):704-713. [http://dx.doi. org/10.1016/j.jpain.2012.04.007]